Approximately 1 in 7 Australian men will be diagnosed with prostate cancer by the age of 75-years-old. Thankfully, innovative research is underway to improve outcomes and save the lives of the men in your life. Continue reading
While there are many treatments available for prostate cancer, once the disease spreads, it becomes more difficult to treat. Professor Greg Goodall and his team at the Centre for Cancer Biology are leading vital research to stop the growth and spread of this devastating disease. They are focused on one crucial molecule which plays an important role in our body – the RNA molecule. Continue reading
Dedicated researcher Dr Irene Zinonos is continuing her groundbreaking research at the Basil Hetzel Institute for Translational Health Research (BHI), working alongside Associate Professor Lisa Butler, to develop a completely new way to predict tumour behaviour and help people make more effective treatment choices. Continue reading
“I feel very strongly about advocating for men’s health and prostate cancer is the most common cancer in men.” Continue reading
An exciting study is underway that could potentially lead to new treatments for metastatic prostate cancer, cancer that has spread to other areas of the body, at the world-class Centre for Cancer Biology in Adelaide.
An exciting project set to explore a newly discovered pathway that could lead to new treatments for metastatic prostate cancer is now underway at the Centre for Cancer Biology (CCB). Supported by Australian Prostate Cancer (APC), with partner The Hospital Research Foundation (THRF), this incredible, innovative research is set to save lives. Continue reading
Current research using the South Australian Prostate Cancer Clinical Outcomes Collaborative (SA-PCCOC) database supported by Australian Prostate Cancer is paving the way in life-changing research. You can feel proud knowing your support will help save lives! Continue reading
A Prostate Cancer Researcher at the University of Adelaide, Dr Rajdeep Das’s research will open up new and exciting avenues for personalised cancer medicine for prostate cancer patients. Continue reading